Αρχειοθήκη ιστολογίου

Δευτέρα 22 Μαΐου 2017

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

Asthma is a common chronic inflammatory disease of the airways that affects an estimated 315 million persons worldwide. Approximately 5 to 10% of persons with asthma have a severe form of disease that is usually managed with high-dose inhaled glucocorticoids and bronchodilators. Within this group,…

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2rJxR3t
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου